Prenatal programming of insulin secretion in intrauterine growth restriction
- PMID: 23820120
- PMCID: PMC4095881
- DOI: 10.1097/GRF.0b013e31829e5b29
Prenatal programming of insulin secretion in intrauterine growth restriction
Abstract
Intrauterine growth restriction (IUGR) impairs insulin secretion in humans and in animal models of IUGR. Several underlying mechanisms have been implicated, including decreased expression of molecular regulators of β-cell mass and function, in some cases shown to be due to epigenetic changes initiated by an adverse fetal environment. Alterations in cell cycle progression contribute to loss of β-cell mass, whereas decreased islet vascularity and mitochondrial dysfunction impair β-cell function in IUGR rodents. Animal models of IUGR sharing similar insulin secretion outcomes as the IUGR human are allowing underlying mechanisms to be identified. This review will focus on models of uteroplacental insufficiency.
References
-
- Newsome CA, Shiell AW, Fall CHD, et al. Is birth weight related to later glucose and insulin metabolism?—a systemic review. Diabetic Med. 2003;20:339–348. - PubMed
-
- Harder T, Rodekamp E, Schellong K, et al. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol. 2007;165:849–857. - PubMed
-
- Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008;300:2886–2897. - PubMed
-
- Eriksson M, Wallander MA, Krakau I, et al. Birth weight and cardiovascular risk factors in a cohort followed until 80 years of age: the study of men born in 1913. J Intern Med. 2004;255:236–246. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
